151 related articles for article (PubMed ID: 23249450)
1. Heart type fatty acid binding protein response and subsequent development of atherosclerosis in insulin resistant polycystic ovary syndrome patients.
Cakir E; Ozbek M; Sahin M; Cakal E; Gungunes A; Ginis Z; Demirci T; Delibasi T
J Ovarian Res; 2012 Dec; 5(1):45. PubMed ID: 23249450
[TBL] [Abstract][Full Text] [Related]
2. Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome.
Karbek B; Ozbek M; Karakose M; Topaloglu O; Bozkurt NC; Cakır E; Aslan MS; Delibasi T
J Ovarian Res; 2014 Mar; 7():31. PubMed ID: 24628831
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
4. Subclinical atherosclerosis and hyperandrogenemia are independent risk factors for increased epicardial fat thickness in patients with PCOS and idiopathic hirsutism.
Cakir E; Doğan M; Topaloglu O; Ozbek M; Cakal E; Vural MG; Yeter E; Delibasi T
Atherosclerosis; 2013 Jan; 226(1):291-5. PubMed ID: 23206979
[TBL] [Abstract][Full Text] [Related]
5. Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome.
Vryonidou A; Papatheodorou A; Tavridou A; Terzi T; Loi V; Vatalas IA; Batakis N; Phenekos C; Dionyssiou-Asteriou A
J Clin Endocrinol Metab; 2005 May; 90(5):2740-6. PubMed ID: 15741256
[TBL] [Abstract][Full Text] [Related]
6. Thrombin-activatable fibrinolysis inhibitor and cardiovascular risk factors in polycystic ovary syndrome.
Erdoğan M; Karadeniz M; Alper GE; Tamsel S; Uluer H; Cağlayan O; Saygili F; Yilmaz C
Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):143-7. PubMed ID: 18350479
[TBL] [Abstract][Full Text] [Related]
7. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.
Bicer M; Guler A; Unal Kocabas G; Imamoglu C; Baloglu A; Bilgir O; Yuksel A; Bozkaya G; Calan M
Endocr Res; 2017 May; 42(2):145-153. PubMed ID: 27911121
[TBL] [Abstract][Full Text] [Related]
8. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
Karadağ C; Yoldemir T
J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome.
Tripathy P; Sahu A; Sahu M; Nagy A
Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():18-22. PubMed ID: 28850821
[TBL] [Abstract][Full Text] [Related]
10. Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome.
Gursoy Calan O; Calan M; Yesil Senses P; Unal Kocabas G; Ozden E; Sari KR; Kocar M; Imamoglu C; Senses YM; Bozkaya G; Bilgir O
Clin Endocrinol (Oxf); 2016 Dec; 85(6):910-917. PubMed ID: 27434652
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Carotid Artery Intima-Media Thickness as a Cardiovascular Risk Factor in Patients With Polycystic Ovary Syndrome.
Yalcin Bahat P; Özel A; Demirci A
Cureus; 2021 Jan; 13(1):e13025. PubMed ID: 33542889
[TBL] [Abstract][Full Text] [Related]
12. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
13. Association of kallistatin with carotid intima-media thickness in women with polycystic ovary syndrome.
Calan M; Guler A; Unal Kocabas G; Alarslan P; Bicer M; Imamoglu C; Yuksel A; Bozkaya G; Bilgir O
Minerva Endocrinol; 2018 Sep; 43(3):236-245. PubMed ID: 28294594
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients.
Cakir E; Ozbek M; Ozkaya E; Colak N; Cakal E; Sayki M; Gungunes A; Aliyazicioglu Y; Mentese A; Delibasi T
J Endocrinol Invest; 2011; 34(7):e178-82. PubMed ID: 21088474
[TBL] [Abstract][Full Text] [Related]
15. Association of increased levels of omentin-1 and carotid intima-media thickness with early signs of cardiovascular risk in patients with polycystic ovary syndrome: A prospective case control study.
Alanya Tosun Ş; Gurbuz T; Cebi A; Tosun A; Gokmen O; Usta M
J Obstet Gynaecol Res; 2022 Jan; 48(1):169-177. PubMed ID: 34676949
[TBL] [Abstract][Full Text] [Related]
16. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
17. Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome.
Hughan KS; Tfayli H; Warren-Ulanch JG; Barinas-Mitchell E; Arslanian SA
J Pediatr; 2016 Jan; 168():104-111.e1. PubMed ID: 26545724
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
19. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism.
Pei YJ; Wang AM; Zhao Y; Yan L; Li M; White RE; Han GC
Gynecol Endocrinol; 2014 Aug; 30(8):553-6. PubMed ID: 24884959
[TBL] [Abstract][Full Text] [Related]
20. Carotid intima-media thickness in mainly non-obese women with polycystic ovary syndrome and age-matched controls.
Kim JJ; Choi YM; Kang JH; Hwang KR; Chae SJ; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
Obstet Gynecol Sci; 2013 Jul; 56(4):249-55. PubMed ID: 24328010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
